David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), sold 5,316 shares at $1.16 ($6K) on 2020-01-03, disclosed to the SEC on 2020-01-07.
Scheduled sale ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTOO | BUY | 2018-06-05 | $32K | — | Filing → |
| TTOO | BUY | 2017-11-17 | $6K | — | Filing → |
| TTOO | BUY | 2017-06-08 | $35K | — | Filing → |